Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 5048-5053

  Taylor, M A ^a   Bennett, M ^a   Kumar, V ^a   Schatzle, J D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOLYSIS; GRAFT REJECTION; IMMUNOMODULATION; LEUKEMIA CELL LINE; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0034326632     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.5048     Document Type: Article

References (36)

1. Biology of natural killer cells
2. Murine natural killer cells and marrow graft rejection
3. In search of the 'missing self': MHC molecules and NK cell recognition
4. Perforin and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity
5. Perforin dependence of natural killer cell-mediated tumor control in vivo
6. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in pefforin-deficient mice
7. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent
8. Fas-mediated cytotoxicity by freshly isolated natural killer cells
9. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
10. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
11. Pefforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells
12. Pefforin gene defects in familial hemophagocytic lymphohistiocytosis
13. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis
14. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice
15. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: Influence of mouse colony environment
16. A central role of perforin in cytolysis?
17. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells
18. Perforin-mediated target cell lysis by cytolytic T lymphocytes
19. Pefforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain
20. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
21. Action of lysosomotropic amines on spontaneous and interferon enhanced NK and CTL cytolysis
22. In vivo effects of chloroquine treatment on spontaneous and interferon-induced natural killer activities in rheumatoid arthritis patients
23. Effects of chloroquine, mefloquine and quinine on natural killer cell activity in vitro. An analysis of the inhibitory mechanism
24. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts
25. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue
26. + T cells
27. Origin and differentiation of natural killer cells. L Characteristics of a transplantable NK cell precursor
28. Lymphocyte proliferative response and subset profiles during extended periods of chloroquine or primaquine prophylaxis
29. Rapid in vivo assay of mouse natural killer cell activity
30. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma
31. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells
32. 2 ligand in microvesicles
33. Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: Does synergy exist?
34. Mechanism of action of hydroxychloroquine as an antirheumatic drug
35. The lysosomotropic amines, chloroquine and hydroxychloroquine: A potentially novel therapy for graft-versus-host disease
36. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites